These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18621598)

  • 1. [New trends in lipidology: the increasing role of HDL-cholesterol].
    Paragh G; Harangi M; László M
    Orv Hetil; 2008 Jul; 149(30):1395-404. PubMed ID: 18621598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Postgrad Med J; 2008 Nov; 84(997):590-8. PubMed ID: 19103817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
    Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels.
    Hausenloy DJ; Yellon DM
    Curr Opin Cardiol; 2009 Sep; 24(5):473-82. PubMed ID: 19574922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the study of anti-atherosclerosis drugs].
    Guo CB; Li S
    Yao Xue Xue Bao; 2007 Mar; 42(3):231-5. PubMed ID: 17520819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HDL and CETP in atherogenesis].
    Pöss J; Böhm M; Laufs U
    Dtsch Med Wochenschr; 2010 Feb; 135(5):188-92. PubMed ID: 20082258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL elevation and lipid lowering therapy: current scenario and future perspectives.
    Chhabria MT; Suhagia BN; Brahmkshatriya PS
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):214-27. PubMed ID: 18221121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets of high-density lipoprotein therapy.
    Nicholls SJ; Nissen SE
    Curr Opin Lipidol; 2007 Aug; 18(4):421-6. PubMed ID: 17620859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
    Taylor AJ
    Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse cholesterol transport in type 2 diabetes mellitus.
    Tan KC
    Diabetes Obes Metab; 2009 Jun; 11(6):534-43. PubMed ID: 19175378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?
    Tavintharan S; Lim SC; Sum CF
    Singapore Med J; 2005 Oct; 46(10):519-28. PubMed ID: 16172771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low high-density lipoprotein cholesterol: current status and future strategies for management.
    Singh V; Sharma R; Kumar A; Deedwania P
    Vasc Health Risk Manag; 2010 Oct; 6():979-96. PubMed ID: 21127701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
    Wierzbicki AS
    Curr Med Res Opin; 2005 Feb; 21(2):299-306. PubMed ID: 15802001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HDL-cholesterol: from risk factor to therapeutic target].
    Lahoz C; Mostaza JM
    Med Clin (Barc); 2009 Jul; 133(6):229-34. PubMed ID: 19535113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL-Targeting Therapeutics: Past, Present and Future.
    Zakiev E; Feng M; Sukhorukov V; Kontush A
    Curr Pharm Des; 2017; 23(8):1207-1215. PubMed ID: 27799042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging strategies for increasing high-density lipoprotein.
    Forrester JS; Shah PK
    Am J Cardiol; 2006 Dec; 98(11):1542-9. PubMed ID: 17126667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.